8-K - Tectonic Therapeutic, Inc. - 5.02 / 7.01 / 9.01
站内整理正文
Form 8-K - Current report: SEC Accession No. 0001193125-26-173829
Filing Date: 2026-04-23
Accepted: 2026-04-23 16:30:31
Documents: 12
Period of Report: 2026-04-23
Items: Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits
Tectonic Therapeutic, Inc. (Filer) CIK : 0001681087 (see all company filings) EIN. : 810710585 | State of Incorp.: NY | Fiscal Year End: 1231 Type: 8-K | Act: 34 | File No.: 001-38537 | Film No.: 26889102 SIC : 2836 Biological Products, (No Diagnostic Substances) (CF Office: 03 Life Sciences)
1 | 8-K | d150495d8k.htm iXBRL | 8-K
2 | EX-99.1 | d150495dex991.htm | EX-99.1
3 | XBRL TAXONOMY EXTENSION SCHEMA | tecx-20260423.xsd | EX-101.SCH
4 | XBRL TAXONOMY EXTENSION LABEL LINKBASE | tecx-20260423_lab.xml | EX-101.LAB